• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫癌肉瘤:临床、组织病理学及免疫组织化学特征

Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.

作者信息

Chen Xiaowei, Arend Rebecca, Hamele-Bena Diane, Tergas Ana I, Hawver Melanie, Tong Guo-Xia, Wright Thomas C, Wright Jason D

机构信息

Departments of Pathology and Cell Biology (X.C., D.H.-B., T.C.W.) Obstetrics and Gynecology, Division of Gynecology Oncology (A.I.T., J.D.W.), Columbia University Medical Center Department of Pathology and Laboratory Medicine, Staten Island University Medical Center, Northwell Health (G.-X.T.), New York Department of Pathology, St. Peter Hospital, Albany (M.H.), New York Department of Obstetrics and Gynecology, Alabama University of Alabama School Medicine, Birmingham, Alabama (R.A.).

出版信息

Int J Gynecol Pathol. 2017 Sep;36(5):412-419. doi: 10.1097/PGP.0000000000000346.

DOI:10.1097/PGP.0000000000000346
PMID:28700424
Abstract

Carcinosarcomas (malignant mixed Müllerian tumors or MMMT) are rare malignant tumors in the female genital tract composed of both malignant epithelial and malignant mesenchymal components. They comprise <5% of all neoplasms in the gynecologic tract and have an aggressive clinical course. The purpose of this study is to evaluate the immunophenotype and possible histogenesis of carcinosarcomas of the uterus. Sixty-two cases of uterine carcinosarcomas diagnosed between 1995 and 2011 were retrieved from the gynecologic pathology files at Columbia University Medical Center. Representative tissue blocks containing both epithelial and mesenchymal components were selected from each case for histologic and immunohistochemical studies. Clinical data from each case were retrieved. The epithelial component was poorly differentiated adenocarcinoma in the majority (80.7%) of cases; in 17.7%, the carcinoma was moderately differentiated, and in only 1.6% the carcinoma was well differentiated. 53% of the tumors had homologous stromal elements and 47% displayed heterologous stromal elements. Immunohistochemical study revealed almost equal staining in both epithelial and mesenchymal components of carcinosarcomas for p16 and p53. PAX8 positivity was noted in 73% of epithelial components, but only 13% of stromal components, and PAX8 stromal positivity was never seen in the absence of PAX8 epithelial positivity. Expression of p16, p53, and PAX8 in both malignant components lends support to the monoclonal theory of uterine carcinosarcoma tumorigenesis. The roles of these tumor markers in the diagnosis and pathogenesis of this tumor and associations between clinical characteristics, tumor pathologic features, and prognosis are discussed.

摘要

癌肉瘤(恶性混合性苗勒管肿瘤或MMMT)是女性生殖道中罕见的恶性肿瘤,由恶性上皮成分和恶性间叶成分组成。它们占妇科肿瘤的比例不到5%,临床病程具有侵袭性。本研究的目的是评估子宫癌肉瘤的免疫表型和可能的组织发生。从哥伦比亚大学医学中心的妇科病理档案中检索出1995年至2011年间诊断的62例子宫癌肉瘤病例。从每个病例中选取包含上皮和间叶成分的代表性组织块进行组织学和免疫组织化学研究。检索每个病例的临床资料。大多数病例(80.7%)的上皮成分是低分化腺癌;17.

相似文献

1
Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.子宫癌肉瘤:临床、组织病理学及免疫组织化学特征
Int J Gynecol Pathol. 2017 Sep;36(5):412-419. doi: 10.1097/PGP.0000000000000346.
2
PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker.妇科癌肉瘤中PD-L1的表达:一种潜在的可作用生物标志物。
Appl Immunohistochem Mol Morphol. 2018 Jul;26(6):393-397. doi: 10.1097/PAI.0000000000000457.
3
Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.子宫癌肉瘤(恶性混合性苗勒管肿瘤):生物学和临床特征阐释的进展
J Natl Compr Canc Netw. 2009 May;7(5):550-6; quiz 557. doi: 10.6004/jnccn.2009.0037.
4
CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.女性生殖道癌肉瘤(恶性混合性苗勒管肿瘤)中的CD34免疫组化显示癌成分起主要作用。
Appl Immunohistochem Mol Morphol. 2000 Dec;8(4):293-9.
5
PAX8 expression in uterine malignant mesodermal mixed tumor (carcinosarcoma).PAX8在子宫恶性中胚叶混合瘤(癌肉瘤)中的表达。
Int J Gynecol Pathol. 2014 Jul;33(4):425-31. doi: 10.1097/PGP.0b013e31829d7705.
6
Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas.子宫癌肉瘤中 EZH2、p16 和 p53 表达的比较分析。
Pathol Oncol Res. 2023 Dec 11;29:1611547. doi: 10.3389/pore.2023.1611547. eCollection 2023.
7
Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors.子宫恶性混合性苗勒管肿瘤中 P16 和 P53 表达的对比分析。
Int J Gynecol Pathol. 2009 Nov;28(6):514-21. doi: 10.1097/PGP.0b013e3181a934e9.
8
Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components.女性生殖道癌肉瘤(恶性混合性苗勒管肿瘤):上皮和间充质成分的比较分子分析
Hum Pathol. 1998 Jan;29(1):82-7. doi: 10.1016/s0046-8177(98)90394-x.
9
Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.子宫癌肉瘤的分子标志物与临床行为:重点关注上皮性肿瘤成分。
Mod Pathol. 2011 Oct;24(10):1368-79. doi: 10.1038/modpathol.2011.88. Epub 2011 May 13.
10
Uterine Carcinosarcomas - Diagnosis and Management.子宫癌肉瘤-诊断与治疗。
Oncol Res Treat. 2018;41(11):675-679. doi: 10.1159/000494335. Epub 2018 Oct 13.

引用本文的文献

1
Spindle cell epithelioma of the vagina with rare morphology: a case report and literature review.阴道梭形细胞上皮瘤伴罕见形态学表现:1例报告及文献复习
Front Oncol. 2025 Aug 4;15:1551607. doi: 10.3389/fonc.2025.1551607. eCollection 2025.
2
Heterochronic pelvic high-grade myxoinflammatory fibroblastic sarcoma and uterine endometroid carcinoma harboring common gene mutations: a rare case report with genomic analysis.异时性盆腔高级别黏液炎性纤维母细胞肉瘤与子宫子宫内膜样癌存在共同基因突变:一项罕见病例报告及基因组分析
Diagn Pathol. 2025 Jun 3;20(1):71. doi: 10.1186/s13000-025-01669-4.
3
Surgical staging identifies occult metastases in over 50% of uterine-confined carcinosarcoma.
手术分期可发现超过50%局限于子宫的癌肉瘤存在隐匿性转移。
Gynecol Oncol Rep. 2025 Mar 18;58:101722. doi: 10.1016/j.gore.2025.101722. eCollection 2025 Apr.
4
Uterine carcinosarcoma with heterologous osseous elements: a case report of an extremely rare clinical occurrence with literature review.伴有异源性骨成分的子宫癌肉瘤:1例极其罕见临床病例报告并文献复习
Front Oncol. 2025 Feb 14;15:1505504. doi: 10.3389/fonc.2025.1505504. eCollection 2025.
5
Utilization of immunohistochemistry in gynecologic tumors: An expert review.免疫组织化学在妇科肿瘤中的应用:专家综述。
Gynecol Oncol Rep. 2024 Nov 29;56:101550. doi: 10.1016/j.gore.2024.101550. eCollection 2024 Dec.
6
Uterine carcinosarcomas: A case series of 9 cases from a low-income country.子宫癌肉瘤:来自一个低收入国家的 9 例病例系列。
Medicine (Baltimore). 2024 Oct 4;103(40):e39773. doi: 10.1097/MD.0000000000039773.
7
Gemcitabine combination therapies induce apoptosis in uterine carcinosarcoma patient-derived organoids.吉西他滨联合疗法可诱导子宫癌肉瘤患者来源的类器官发生凋亡。
Front Oncol. 2024 Mar 13;14:1368592. doi: 10.3389/fonc.2024.1368592. eCollection 2024.
8
Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas.子宫癌肉瘤中 EZH2、p16 和 p53 表达的比较分析。
Pathol Oncol Res. 2023 Dec 11;29:1611547. doi: 10.3389/pore.2023.1611547. eCollection 2023.
9
The prognostic significance of the heterologous component in uterine carcinosarcomas.子宫癌肉瘤中异源成分的预后意义。
Rev Assoc Med Bras (1992). 2023 Sep 18;69(9):e20230517. doi: 10.1590/1806-9282.20230517. eCollection 2023.
10
A personalized nomogram for predicting 3-year overall survival of patients with uterine carcinosarcoma in a tertiary care hospital in Southern Thailand.泰国南部一家三级护理医院中用于预测子宫癌肉瘤患者3年总生存率的个性化列线图。
Obstet Gynecol Sci. 2023 May;66(3):198-207. doi: 10.5468/ogs.22262. Epub 2023 Mar 23.